Feifei Wu

1.7k total citations
61 papers, 1.3k citations indexed

About

Feifei Wu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Feifei Wu has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Feifei Wu's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Mitochondrial Function and Pathology (4 papers). Feifei Wu is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Mitochondrial Function and Pathology (4 papers). Feifei Wu collaborates with scholars based in China, United States and Germany. Feifei Wu's co-authors include Liji Jin, Huaqiang Li, Shuying Li, Yongping Xu, Longxuan Li, Jiansong You, Limin Xu, Liying Cai, Yufeng Jiang and Xiaoyin Lai and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Scientific Reports.

In The Last Decade

Feifei Wu

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Wu China 20 767 316 213 147 116 61 1.3k
Hanna Lee South Korea 18 580 0.8× 198 0.6× 356 1.7× 137 0.9× 118 1.0× 44 1.4k
Liguo Zhang China 19 697 0.9× 253 0.8× 183 0.9× 75 0.5× 95 0.8× 44 1.4k
Dandan Wang China 24 982 1.3× 221 0.7× 389 1.8× 157 1.1× 49 0.4× 105 1.7k
Min Xia China 19 545 0.7× 269 0.9× 97 0.5× 110 0.7× 87 0.8× 39 1.1k
Meifeng Yang China 25 704 0.9× 184 0.6× 141 0.7× 116 0.8× 61 0.5× 59 1.6k
Hyun Jae Lee South Korea 18 647 0.8× 143 0.5× 247 1.2× 144 1.0× 64 0.6× 62 1.3k
Lu Gao China 19 646 0.8× 200 0.6× 276 1.3× 176 1.2× 39 0.3× 70 1.2k
Feng Tang China 21 656 0.9× 372 1.2× 161 0.8× 135 0.9× 46 0.4× 82 1.4k
Johannes F. W. Greiner Germany 19 525 0.7× 246 0.8× 130 0.6× 175 1.2× 47 0.4× 46 1.1k

Countries citing papers authored by Feifei Wu

Since Specialization
Citations

This map shows the geographic impact of Feifei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Wu more than expected).

Fields of papers citing papers by Feifei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Wu. The network helps show where Feifei Wu may publish in the future.

Co-authorship network of co-authors of Feifei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Wu. A scholar is included among the top collaborators of Feifei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Wu. Feifei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhu, Chunhong, Zhipeng Lin, Ke Tian, et al.. (2025). Pharmacological and Genetic Approaches to Downregulate FIS1 Mitigate Neuropathic Pain. Journal of Neuroscience. 45(35). e0523252025–e0523252025.
3.
Huang, Xinshuo, Shuang Huang, Zhengjie Liu, et al.. (2024). Integrated electronic/fluidic microneedle system for glucose sensing and insulin delivery. Theranostics. 14(4). 1662–1682. 12 indexed citations
4.
Wei, Wei, Feifei Wu, Jingxia Li, et al.. (2024). FGF21 overexpression alleviates VSMC senescence in diabetic mice by modulating the SYK-NLRP3 inflammasome-PPARγ-catalase pathway. Acta Biochimica et Biophysica Sinica. 56(6). 892–904.
5.
Li, Xiaodong, Zhenhua Wang, Feifei Wu, et al.. (2024). Targeting DNM1L/DRP1-FIS1 axis inhibits high-grade glioma progression by impeding mitochondrial respiratory cristae remodeling. Journal of Experimental & Clinical Cancer Research. 43(1). 273–273. 7 indexed citations
6.
Liu, Haihua, Wei Wei, Feifei Wu, et al.. (2024). Sodium tanshinone IIA sulfonate protects vascular relaxation in ApoE-knockout mice by inhibiting the SYK-NLRP3 inflammasome-MMP2/9 pathway. BMC Cardiovascular Disorders. 24(1). 354–354. 4 indexed citations
7.
Liu, Xiaoyan, Feifei Wu, Ye Wu, et al.. (2024). Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis. BMJ Open. 14(1). e071548–e071548. 2 indexed citations
8.
Huang, Shuang, Chuanjie Yao, Xinshuo Huang, et al.. (2023). Semi-implantable device based on multiplexed microfilament electrode cluster for continuous monitoring of physiological ions. Bio-Design and Manufacturing. 7(1). 88–103. 5 indexed citations
9.
Huang, Xinshuo, et al.. (2023). 3D-assembled microneedle ion sensor-based wearable system for the transdermal monitoring of physiological ion fluctuations. Microsystems & Nanoengineering. 9(1). 25–25. 43 indexed citations
10.
Wu, Feifei, Huiyu Li, Qi An, et al.. (2023). Discovery of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors. European Journal of Medicinal Chemistry. 254. 115355–115355. 16 indexed citations
11.
Wu, Feifei, et al.. (2023). EP022 / #257 LONG-TERM OUTCOMES OF VAGUS NERVE STIMULATION IN TREATMENT-RESISTANT DEPRESSION. Neuromodulation Technology at the Neural Interface. 26(8). S13–S13. 1 indexed citations
12.
Sun, Xiaojie, Na Li, Xiaolei Wang, et al.. (2022). PEG-mediated hybrid hemostatic gauze with in-situ growth and tightly-bound mesoporous silicon. Biomaterials Advances. 143. 213179–213179. 9 indexed citations
13.
Wang, Weimin, et al.. (2021). Identification of Potential Signatures and Their Functions for Acute Lymphoblastic Leukemia: A Study Based on the Cancer Genome Atlas. Frontiers in Genetics. 12. 656042–656042. 14 indexed citations
14.
Luo, Tingting, Chun‐Qiu Dai, Zhengmei Wang, et al.. (2020). Drp1 is widely, yet heterogeneously, distributed in the mouse central nervous system. Molecular Brain. 13(1). 90–90. 8 indexed citations
15.
16.
Chen, Qinqin, Fangfang Niu, Jingli Yan, et al.. (2017). Oilseed rape NAC56 transcription factor modulates reactive oxygen species accumulation and hypersensitive response‐like cell death. Physiologia Plantarum. 160(2). 209–221. 19 indexed citations
18.
Khan, Khaleel Ur Rahman, et al.. (2015). Information Content Based Semantic Similarity Measure for Concepts Subsumed By Multiple Concepts. 7(3). 85–94. 4 indexed citations
19.
Wu, Feifei, Huaqiang Li, Liangzhong Zhao, et al.. (2013). Protective effects of aqueous extract from Acanthopanax senticosus against corticosterone-induced neurotoxicity in PC12 cells. Journal of Ethnopharmacology. 148(3). 861–868. 46 indexed citations
20.
Wu, Feifei, Huaqiang Li, Liji Jin, et al.. (2012). Deer antler base as a traditional Chinese medicine: A review of its traditional uses, chemistry and pharmacology. Journal of Ethnopharmacology. 145(2). 403–415. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026